Trial
NCT01161641
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Protein Losing Enteropathy
Intervention
ODSH at 0.125 mg/kg/h
Why stopped
Extremely slow accural due to rarity of medical condition studied.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-02